OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatitis delta virus: Disease assessment and stratification
Apostolos Koffas, Lung‐Yi Mak, Patrick Kennedy
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 12-21
Open Access | Times Cited: 7
Apostolos Koffas, Lung‐Yi Mak, Patrick Kennedy
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 12-21
Open Access | Times Cited: 7
Showing 7 citing articles:
microRNAs in parasite-induced liver fibrosis: from mechanisms to diagnostics and therapeutics
Mengqi Liu, William C. Cho, Robin J. Flynn, et al.
Trends in Parasitology (2023) Vol. 39, Iss. 10, pp. 859-872
Open Access | Times Cited: 8
Mengqi Liu, William C. Cho, Robin J. Flynn, et al.
Trends in Parasitology (2023) Vol. 39, Iss. 10, pp. 859-872
Open Access | Times Cited: 8
Seroprevalence Trends and Molecular Epidemiology of Viral Hepatitis in Croatia
Tatjana Vilibić‐Čavlek, Snježana Židovec Lepej, Thomas Ferenc, et al.
Life (2023) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 5
Tatjana Vilibić‐Čavlek, Snježana Židovec Lepej, Thomas Ferenc, et al.
Life (2023) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 5
State of the Art
Emuejevuoke Umukoro, Joseph J. Alukal, Kevin Pak, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 4, pp. 937-954
Closed Access | Times Cited: 5
Emuejevuoke Umukoro, Joseph J. Alukal, Kevin Pak, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 4, pp. 937-954
Closed Access | Times Cited: 5
Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review
Milaveh Assadi-Rad, Brenda E. Acosta, Matthew C. Hesterman, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 1
Milaveh Assadi-Rad, Brenda E. Acosta, Matthew C. Hesterman, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 1
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access
Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
Roxana Nemțeanu, Andreea Clim, Corina Elena Hincu, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7878-7890
Open Access | Times Cited: 1
Roxana Nemțeanu, Andreea Clim, Corina Elena Hincu, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7878-7890
Open Access | Times Cited: 1
Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review
Milaveh Assadi-Rad, Brenda E. Acosta, Matthew C. Hesterman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Milaveh Assadi-Rad, Brenda E. Acosta, Matthew C. Hesterman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
